Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Rocket Pharmaceuticals, Inc. (RCKT) had Debt to Capital Ratio of 0.04 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-61.33M |
|
-- |
|
-- |
|
$64.39M |
|
$-64.39M |
|
$3.05M |
|
$-61.33M |
|
$-61.33M |
|
$-61.33M |
|
$-61.33M |
|
$-61.33M |
|
$-61.33M |
|
$-64.39M |
|
$-61.40M |
|
110.09M |
|
110.09M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$324.49M |
|
$34.56M |
|
$146.57M |
|
$471.07M |
|
$35.31M |
|
$19.38M |
|
$23.62M |
|
$58.93M |
|
$412.14M |
|
$347.83M |
|
$412.14M |
|
106.75M |
|
| Cash Flow Statement Financials | |
$-55.79M |
|
$-58.03M |
|
-- |
|
$165.00M |
|
$51.17M |
|
$-113.83M |
|
$10.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.19 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.04 |
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-56.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.88% |
|
-17.63% |
|
-13.02% |
|
-14.21% |
|
$3.86 |
|
$-0.51 |
|
$-0.51 |
|